ORTEXORTEX News
Tracking MPC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
MP
Earnings PreviewMPC

MPC Earnings Preview: Analysts Converge as Peers Fall Harder

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 24 Oct 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Marathon Petroleum sits in the middle of a refining sector sell-off, but its positioning ahead of Monday's earnings is notably cleaner than most of its closest peers.

Among the most correlated refiners, PBF dropped nearly 9% on the week and VLO fell 4%. CVI shed almost 5% and CLMT fell more than 15%. MPC declined 4.4%, roughly in line with the peer median of 4.1%, but the similarity in price moves masks a meaningful difference in how the stock is positioned. Short interest is 2.25% of the free float, one of the lower readings across the refining group, and has dropped 25% over the past month as shares rallied 17%. Availability in the borrow market has actually loosened further this week, now running above 3,400%, meaning there are far more shares available to borrow than are currently borrowed. The cost to borrow is 0.35%, barely above zero.

Options tell a different story than the short market. The put/call ratio has fallen to 1.06, nearly 1.7 standard deviations below its 20-day mean of 1.15. That reading is toward the low end of the past year's range and marks a sharp rotation from mid-October, when the PCR hit its 52-week high of 1.25. The shift reflects investors buying fewer puts relative to calls as the stock held up against sector weakness. Whether that reflects growing conviction or simply the unwinding of pre-existing hedges is the open question.

The analyst community has moved aggressively in MPC's favor over the past two weeks. TD Cowen raised its target to $478 on October 22, keeping a Buy. Wells Fargo set the high-water mark at $560 in mid-October. Barclays and Citigroup both lifted targets above $488. The mean consensus target now sits at $459, essentially in line with the $457 close on Thursday. That gap has compressed dramatically from a month ago, when the stock was trading well above the then-prevailing consensus. The bull case rests on refining capture running above 100% of benchmark spreads, an exceptionally strong balance sheet with roughly $6.7 billion in parent cash, and MPLX distributions covering dividend and capital expenditure needs without touching refinery cash flow. Bears point to the exposure to spot refining margins, which remain cyclically vulnerable, and to operational disruptions in Q1 that marked the worst unplanned downtime in a decade.

EPS momentum factor scores rank in the 90th and 94th percentile on 30-day and 90-day windows respectively, reflecting the run of estimate upgrades. That momentum has done most of the work in driving the stock's 17% monthly gain. The print will test whether the underlying refining margin picture in Q3 justifies the reset in analyst targets, or whether the rally has run ahead of what the actual quarter can deliver.

Stocks in this article

See the live data behind this article on ORTEX.

Open MPC on ORTEX →

How this article was generated

Generated
24 Oct 2026, 04:19
Data as of
24 Oct 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.